SSSanjay Kumar Singh

Sanjay Kumar Singh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sanjay Kumar Singh has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • MEDIATOR25 integrates jasmonate signaling with specialized metabolism across alkaloid and flavonoid pathways

    by Joshua J Singleton, Craig Schluttenhofer, Barunava Patra, Sanjay K Singh, Xia Wu, Ruiqing Lyu, Sitakanta Pattanaik, Ling Yuan

    MEDIATOR 25 (MED25) is a key component of the universally conserved multi-subunit mediator complex. In plants, MED25 regulates diverse biological processes, including flowering, seed germination, cell proliferation, defense responses, and phytohormone signaling, largely through interactions with transcription factors. However, its role in specialized metabolism remains poorly understood. MED25 is a crucial component of the jasmonate (JA) signaling pathway, and JA is a major elicitor of specialized metabolites such as terpenoid indole alkaloids (TIAs) in Madagascar periwinkle (Catharanthus roseus) and flavonoids in Arabidopsis (Arabidopsis thaliana). Using C. roseus and Arabidopsis as models, we investigated the regulatory role of MED25 in these 2 distinct metabolic pathways. RNAi-mediated silencing of CrMED25 in C. roseus hairy roots significantly altered the expression of TIA biosynthetic genes and reduced TIA accumulation. We demonstrated that CrMED25 interacts with CrMYC2 and C. roseus jasmonate ZIM domain 1 (CrJAZ1), key regulators of the TIA pathway. Additionally, CrMED25 silencing suppressed the expression of flavonoid pathway genes in C. roseus hairy roots and flowers. Parallel analysis in Arabidopsis showed that the med25 mutant exhibited strong repression of flavonoid pathway genes and regulators. Protein–protein interaction assays revealed that AtMED25 interacts with GLABRA3 (GL3), MYB12, and MYB111, well-established regulators of flavonoid biosynthesis. These findings establish MED25 as a conserved co-activator of specialized metabolism, integrating JA signaling with transcriptional programs governing alkaloid and flavonoid biosynthesis. This work uncovers a previously unrecognized regulatory role of MED25 and highlights molecular entry points for engineering pharmaceutically important plant metabolites.


  • Open Access

    Post-translational control of biotic stress-related nicotine biosynthesis by a MAP kinase signaling cascade

    by Yan Zhou, Yongliang Liu, Ruiqing Lyu, Sanjay Kumar Singh, Xueyi Sui, Xin Hou, Sitakanta Pattanaik, Ling Yuan


  • Mitogen-activated protein kinase-mediated regulation of plant specialized metabolism

    by Yan Zhou, Sanjay Kumar Singh, Barunava Patra, Yongliang Liu, Sitakanta Pattanaik, Ling Yuan

    Post-transcriptional and post-translational modification of transcription factors (TFs) and pathway enzymes significantly affect the stress-stimulated biosynthesis of specialized metabolites (SMs). Protein phosphorylation is one of the conserved and ancient mechanisms that critically influences many biological processes including specialized metabolism. The phosphorylation of TFs and enzymes by protein kinases (PKs), especially the mitogen-activated protein kinases (MAPKs), is well studied in plants. While the roles of MAPKs in plant growth and development, phytohormone signaling, and immunity are well elucidated, significant recent advances have also been made in understanding the involvement of MAPKs in specialized metabolism. However, a comprehensive review highlighting the significant progress in the past several years is notably missing. This review focuses on MAPK-mediated regulation of several important SMs, including phenylpropanoids (flavonoids and lignin), terpenoids (artemisinin and other terpenoids), alkaloids (terpenoid indole alkaloids and nicotine), and other nitrogen- and sulfur-containing SMs (camalexin and indole glucosinolates). In addition to MAPKs, other PKs also regulate SM biosynthesis. For comparison, we briefly discuss the regulation by other PKs, such as sucrose non-fermenting-1 (SNF)-related protein kinases (SnRKs) and calcium-dependent protein kinases (CPKs). Furthermore, we provide future perspectives in this active area of research.


  • Top Cited Papers
    Open Access

    Light regulation of the biosynthesis of phenolics, terpenoids, and alkaloids in plants

    by Yongliang Liu, Sanjay K. Singh, Sitakanta Pattanaik, Hongxia Wang, Ling Yuan

    Biosynthesis of specialized metabolites (SM), including phenolics, terpenoids, and alkaloids, is stimulated by many environmental factors including light. In recent years, significant progress has been made in understanding the regulatory mechanisms involved in light-stimulated SM biosynthesis at the transcriptional, posttranscriptional, and posttranslational levels of regulation. While several excellent recent reviews have primarily focused on the impacts of general environmental factors, including light, on biosynthesis of an individual class of SM, here we highlight the regulation of three major SM biosynthesis pathways by light-responsive gene expression, microRNA regulation, and posttranslational modification of regulatory proteins. In addition, we present our future perspectives on this topic.


  • Open Access

    Terpenoid indole alkaloid biosynthesis in Catharanthus roseus: effects and prospects of environmental factors in metabolic engineering

    by Yongliang Liu, Barunava Patra, Sanjay Kumar Singh, Priyanka Paul, Yan Zhou, Yongqing Li, Ying Wang, Sitakanta Pattanaik, Ling Yuan

    Plants synthesize a vast array of specialized metabolites that primarily contribute to their defense and survival under adverse conditions. Many of the specialized metabolites have therapeutic values as drugs. Biosynthesis of specialized metabolites is affected by environmental factors including light, temperature, drought, salinity, and nutrients, as well as pathogens and insects. These environmental factors trigger a myriad of changes in gene expression at the transcriptional and posttranscriptional levels. The dynamic changes in gene expression are mediated by several regulatory proteins that perceive and transduce the signals, leading to up- or down-regulation of the metabolic pathways. Exploring the environmental effects and related signal cascades is a strategy in metabolic engineering to produce valuable specialized metabolites. However, mechanistic studies on environmental factors affecting specialized metabolism are limited. The medicinal plantCatharanthus roseus(Madagascar periwinkle) is an important source of bioactive terpenoid indole alkaloids (TIAs), including the anticancer therapeutics vinblastine and vincristine. The emerging picture shows that various environmental factors significantly alter TIA accumulation by affecting the expression of regulatory and enzyme-encoding genes in the pathway. Compared to our understanding of the TIA pathway in response to the phytohormone jasmonate, the impacts of environmental factors on TIA biosynthesis are insufficiently studied and discussed. This review thus focuses on these aspects and discusses possible strategies for metabolic engineering of TIA biosynthesis.Purpose of work: Catharanthus roseusis a rich source of bioactive terpenoid indole alkaloids (TIAs). The objective of this work is to present a comprehensive account of the influence of various biotic and abiotic factors on TIA biosynthesis and to discuss possible strategies to enhance TIA production through metabolic engineering.


  • Open Access

    BHLH IRIDOID SYNTHESIS 3 is a member of a bHLH gene cluster regulating terpenoid indole alkaloid biosynthesis in Catharanthus roseus

    by Sanjay Kumar Singh, Barunava Patra, Priyanka Paul, Yongliang Liu, Sitakanta Pattanaik, Ling Yuan

    Basic helix‐loop‐helix (bHLH) transcription factors (TFs) are key regulators of plant specialized metabolites, including terpenoid indole alkaloids (TIAs) in Catharanthus roseus. Two previously characterized subgroup‐IVa bHLH TFs, BIS1 (bHLH Iridoid Synthesis 1) and BIS2 regulate iridoid biosynthesis in the TIA pathway. We reanalyzed the recently updated C. roseus genome sequence and discovered that BIS1 and BIS2 are clustered on the same genomic scaffold with a previously uncharacterized bHLH gene, designated as BIS3. Only a few bHLH gene clusters have been studied to date. Comparative analysis of 49 genome sequences from different plant lineages revealed the presence of analogous bHLH clusters in core angiosperms, including the medicinal plants Calotropis gigantea (giant milkweed) and Gelsemium sempervirens (yellow jessamine), but not in the analyzed basal angiosperm and lower plants. Similar to the iridoid pathway genes, BIS3 is highly expressed in roots and induced by methyl jasmonate. BIS3 activates the promoters of iridoid branch genes, geraniol synthase (GES), geraniol 10‐hydroxylase (G10H), 8‐hydroxygeraniol oxidoreductase (8HGO), iridoid synthase (IS), 7‐deoxyloganetic acid glucosyl transferase (7‐DLGT), and 7‐deoxyloganic acid hydroxylase (7DLH), but not iridoid oxidase (IO). Transactivation of the promoters was abolished when BIS3 is converted to a dominant repressor by fusing with the ERF‐associated amphiphilic repression (EAR) sequence. In addition, BIS3 acts synergistically with BIS1 and BIS2 to activate the G10H promoter in tobacco cells. Mutation of the known bHLH TF binding motif, G‐box (CACGTG) in the G10H promoter significantly reduced but did not abolish the transactivation by BIS3. Promoter deletion analysis of G10H suggests that the sequences adjacent to the G‐box are also involved in the regulation by BIS3. Overexpression of BIS3 in C. roseus flower petals significantly upregulated the expression of iridoid biosynthetic genes and increased loganic acid accumulation. BIS2 expression was significantly induced by BIS3 although BIS3 did not directly activate the BIS2 promoter. Our results advance our understanding of the regulation of plant specialized metabolites by bHLH TF clusters.


  • Open Access

    Protein phosphatase NtPP2C2b and MAP kinase NtMPK4 act in concert to modulate nicotine biosynthesis

    by Xiaoyu Liu, Sanjay Kumar Singh, Barunava Patra, Yongliang Liu, Bingwu Wang, Jinsheng Wang, Sitakanta Pattanaik, Ling Yuan

    Protein phosphatases (PPs) and protein kinases (PKs) regulate numerous developmental, defense, and phytohormone signaling processes in plants. However, the underlying regulatory mechanism governing biosynthesis of specialized metabolites, such as alkaloids, by the combined effects of PPs and PKs, is insufficiently understood. Here, we report the characterization of a group B protein phosphatase type 2C, NtPP2C2b, that likely acts upstream of the NICOTINE2 locus APETALA 2/Ethylene Response Factors (AP2/ERFs), to regulate nicotine biosynthesis in tobacco. Similar to the nicotine pathway genes, NtPP2C2b is highly expressed in roots and induced by jasmonic acid (JA). Overexpression of NtPP2C2b in transgenic hairy roots or stable transgenic tobacco plants repressed nicotine pathway gene expression and reduced nicotine accumulation. Additionally, transient overexpression of NtPP2C2b, together with the NtERF221, repressed transactivation of the quinolinate phosphoribosyltransferase promoter in tobacco cells. We further demonstrate that the JA-responsive tobacco mitogen-activated protein kinase (MAPK) 4 interacts with NtPP2C2b in yeast and plant cells. Conditional overexpression of NtMPK4 in tobacco hairy roots up-regulated nicotine pathway gene expression and increased nicotine accumulation. Our findings suggest that a previously uncharacterized PP-PK module acts to modulate alkaloid biosynthesis, highlighting the importance of post-translational control in the biosynthesis of specialized plant metabolites.


  • Maleic hydrazide elicits global transcriptomic changes in chemically topped tobacco to influence shoot bud development

    by Sanjay K. Singh, Mitchell D. Richmond, Robert C. Pearce, William A. Bailey, Xin Hou, Sitakanta Pattanaik, Ling Yuan

    Transcriptomic analysis revealed maleic hydrazide suppresses apical and axillary bud development by altering the expression of genes related to meristem de


  • Open Access

    Conformationally Altered C-Reactive Protein Capable of Binding to Atherogenic Lipoproteins Reduces Atherosclerosis

    by Asmita Pathak, Sanjay K. Singh, Douglas P. Thewke, Alok Agrawal

    The aim of this study was to test the hypothesis that C-reactive protein (CRP) protects against the development of atherosclerosis and that a conformational alteration of wild-type CRP is necessary for CRP to do so. Atherosclerosis is an inflammatory cardiovascular disease and CRP is a plasma protein produced by the liver in inflammatory states. The co-localization of CRP and low-density lipoproteins (LDL) at atherosclerotic lesions suggests a possible role of CRP in atherosclerosis. CRP binds to phosphocholine-containing molecules but does not interact with LDL unless the phosphocholine groups in LDL are exposed. However, CRP can bind to LDL, without the exposure of phosphocholine groups, if the native conformation of CRP is altered. Previously, we reported a CRP mutant, F66A/T76Y/E81A, generated by site-directed mutagenesis, that did not bind to phosphocholine. Unexpectedly, this mutant CRP, without any more conformational alteration, was found to bind to atherogenic LDL. We hypothesized that this CRP mutant, unlike wild-type CRP, could be anti-atherosclerotic and, accordingly, the effects of mutant CRP on atherosclerosis in atherosclerosis-prone LDL receptor-deficient mice were evaluated. Administration of mutant CRP into mice every other day for a few weeks slowed the progression of atherosclerosis. The size of atherosclerotic lesions in the aorta of mice treated with mutant CRP for 9 weeks was ~40% smaller than the lesions in the aorta of untreated mice. Thus, mutant CRP conferred protection against atherosclerosis, providing a proof of concept that a local inflammation-induced structural change in wild-type CRP is a prerequisite for CRP to control the development of atherosclerosis.


  • Effect of dietary n‐3 polyunsaturated fatty acid supplementation on the expression of genes involved in progesterone biosynthesis in the corpus luteum of goat (Capra hircus)

    by Ravjibhai Karshanbhai Chaudhari, Ajit Singh Mahla, Sanjay Kumar Singh, Abhijit M. Pawde, Surendra Kumar Badasara, Harendra Kumar, Manas Kumar Patra, Narayanan Krishnaswamy

    Emerging evidence indicates that dietary n‐3 polyunsaturated fatty acids (PUFA) alter the fatty acid composition of corpus luteum (CL) and directly affect the luteal function in the cow, which is independent of the inhibitory effect on the endometrial PGF2α production. The present study, thus, investigated the effects of n‐3 PUFA rich fish oil (FO) supplementation on the transcriptional modulation of genes involved in the biosynthesis of progesterone (P4) in the CL collected during the luteolytic phase of oestrous cycle in the goat. On the day of synchronized oestrus, goats (n = 6/group) were fed an isocaloric diet supplemented with either FO or palm oil (PO). The dose of oil supplementation was 0.6 mlkg‐1 body weight, and the duration was 55–57 days. The FO provided 156 mgkg‐1 body weight of n‐3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The CL was collected by laparotomy on day 16 post‐oestrus, and the relative abundance of P450 side‐chain cleaving enzyme, steroid acute regulatory protein (StAR) and 3β‐hydroxy steroid dehydrogenase (3β‐HSD) genes was quantitated by real‐time PCR. The results indicated that the dietary FO significantly upregulated the expression of 3β‐HSD by 1.13‐fold and downregulated StAR by ~2‐fold as compared to PO group (p < .05). It is concluded that dietary FO differently affected the expression of genes involved in P4 synthesis in the CL during the luteolytic window of the oestrous cycle in the goat.